Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

417657

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the level of provision of pancreatic cancer treatment on the NHS; and if he will make a statement.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	9405
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>Over the last 15 years, services for pancreatic cancer have been significantly strengthened within the National Health Service. This includes clearer diagnostic pathways, decision making by specialist multi-disciplinary teams and centralisation of pancreas surgery within specialist teams.</p><p> </p><p> </p><p> </p><p>Between 1999 and 2009, following reorganisation of pancreas services, there are now twice as many patients accessing surgery, and one year survival has increased by 5%. The benefits of the United Kingdom model are recognised internationally.</p><p> </p><p> </p><p> </p><p>It is recognised that pancreatic cancer is a challenging disease for a number of reasons. There is a lack of any effective drug therapies and research opportunities are restricted by the small number of patients with the disease (approximately 7,000 annually), and the relatively low survival rates.</p><p> </p><p> </p><p> </p><p>Symptoms are variable and difficult to identify, and there is presently no diagnostic test, although a test is in the research phase.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/09/2015 12:25:49 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

417658

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that expert clinicians are consulted when assessing new treatments for pancreatic cancer.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	9406
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>The National Institute for Health and Care Excellence’s (NICE) guidance is based on a thorough assessment of the available evidence and is developed through wide consultation with stakeholders. NICE makes every effort to ensure that appropriate stakeholders, including clinical experts, are able to engage with the development of its guidance.</p><p> </p><p> </p><p> </p><p>As part of NICE’s technology appraisal process, clinical specialists, commissioning experts and patient experts are invited by the Appraisal Committee to provide written evidence and attend the Committee meeting to help in the Committee's discussion of the technology being appraised.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for administering the Cancer Drugs Fund (CDF) and decisions on which treatments are included on the national CDF list are made by the CDF clinical panel. The panel includes expert oncologists, oncology pharmacists and patient representatives.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/09/2015 11:55:39 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

417659

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nurses: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the cost to the public purse of training a UK citizen as a nurse; and what assessment he has made of how this figure compares with the costs of recruiting nurses from overseas.
tabling member constituency	Twickenham
tabling member printed	Dr Tania Mathias
uin	9401
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>The Personal Social Services Research Unit at the University of Kent estimates that the average cost of training a nurse in 2013 was £78,604. This figure reflects the total cost of training and therefore includes costs funded through the public purse, including the NHS bursary, and by the student.</p><p> </p><p> </p><p> </p><p>National Health Service organisations are best placed to decide how many staff they employ and how best to recruit those staff to meet services tailored to the needs of their patients and local communities, to deliver safe care.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 11/09/2015 12:07:22 answering member 3988 label Biography information for Ben Gummer
tabling member	4404 label Biography information for Dr Tania Mathias

417660

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Mortality Rates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of changes in cancer survival rates in each of the last five years.
tabling member constituency	Coventry North East
tabling member printed	Colleen Fletcher
uin	9393
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>The Independent Cancer Taskforce’s new strategy, <em>Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020</em>, which recommends improvements across the cancer pathway, was published on 19 July 2015. It will reduce incidence of cancer and improve services and outcomes for cancer patients, in particular survival rates. We will work with the National Health Service, charities and patient groups to deliver it.</p><p> </p><p> </p><p> </p><p>Our cancer survival rates are at an all-time high and continue to improve, but we know we need to do more to be among the best in the world, and that is what we aim to achieve.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/09/2015 13:13:15 answering member 3918 label Biography information for Jane Ellison
tabling member	4378 label Biography information for Colleen Fletcher

417663

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to reduce the mortality rate from drug misuse in the North East.
tabling member constituency	Middlesbrough South and East Cleveland
tabling member printed	Tom Blenkinsop
uin	9389
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>The latest rise in drug misuse deaths – particularly in the North East – is a great concern and highlights the need for further local and national action. We need to ensure the most vulnerable users can access drug treatment and harm reduction services, where they have the best chance of recovery.</p><p> </p><p> </p><p> </p><p>Public Health England will continue to support local authorities in delivering effective recovery services for everyone who needs them. They are providing local authorities and commissioners with expert advice, evidence, and management information including outcomes and value for money data. This can help to ensure that the local services are evidence-based, effective and integrated with local health, housing and employment support.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/09/2015 13:27:25 answering member 3918 label Biography information for Jane Ellison
tabling member	4037 label Biography information for Tom Blenkinsop

417664

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the reasons are for the most recent NHS England review of the pancreatic cancer drug available on the national Cancer Drugs Fund.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	9391
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>The Cancer Drugs Fund panel considered a number of drug/indications for reprioritisation in July 2015. The panel’s decisions were announced on 4 September 2015 and are available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/pe/cdf/cdf-drug-sum/" target="_blank">www.england.nhs.uk/ourwork/pe/cdf/cdf-drug-sum/</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/09/2015 11:57:19 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

417665

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with which patient groups did NHS England consult before the decision was taken to remove 25 treatments from the Cancer Drugs Fund.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	9395
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>The national Cancer Drugs Fund Panel followed NHS England’s Standard Operating Procedures for the Cancer Drugs Fund during the process of decision making. The Panel includes members from patient groups. In accordance with the Standard Operating Procedures, delegated members of the panel met with patient groups this week to explain the panel’s decisions.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/09/2015 11:59:14 answering member 4020 label Biography information for George Freeman
tabling member	4212 label Biography information for Debbie Abrahams

417666

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the number of patients who will be denied access to treatments no longer available on the national Cancer Drugs Fund list from 4 November 2015.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	9396
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>NHS England is working with manufacturers seeking to maintain drug and indication combinations within the Cancer Drugs Fund.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/09/2015 12:04:15 answering member 4020 label Biography information for George Freeman
tabling member	4212 label Biography information for Debbie Abrahams

417668

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Maternity Leave
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many and what proportion of GP maternity cover posts have been left unfilled in each year since 2010.
tabling member constituency	Ashfield
tabling member printed	Gloria De Piero
uin	9490
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>This information is not collected centrally.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 11/09/2015 12:12:49 answering member 1201 label Biography information for Alistair Burt
tabling member	3915 label Biography information for Gloria De Piero

417677

registered interest
date	08/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nurses: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of the budget made available for nurse recruitment by NHS trusts in England and Wales in each of the next five years.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	9652
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>National Health Service organisations are best placed to decide how many staff they employ and how best to recruit those staff to meet services tailored to the needs of their patients and local communities, to deliver safe care.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 11/09/2015 12:24:18 answering member 3988 label Biography information for Ben Gummer
tabling member	308 label Biography information for Mr Jim Cunningham